NewSquare Capital’s Agios Pharmaceuticals AGIO Stock Holding History

NewSquare Capital’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,000	Closed	-$46K	–	326
2018 Q4	$46K	Hold	1,000	–	–	0.01%	157
2018 Q3	$77K	Sell	1,000 -1,000	-50%	-$80.4K	0.01%	146
2018 Q2	$182K	Buy	+2,000	New	+$174K	0.04%	116

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NewSquare Capital's AGIO Position: Q1 2019 in Review

NewSquare Capital sold out of Agios Pharmaceuticals (AGIO) in Q1 2019, closing a stake of 1,000 shares — an estimated $46K sold.

NewSquare Capital first reported a position in AGIO in Q2 2018 and held it in 3 quarters. The position peaked at $182K in Q2 2018. 201 funds tracked by Wall St. Rank hold AGIO as of Q1 2019.

NewSquare Capital reported no remaining Agios Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
NewSquare Capital sold 1,000 Agios Pharmaceuticals shares in Q1 2019, an estimated $46K.
NewSquare Capital first reported a position in Agios Pharmaceuticals in Q2 2018 and held it in 3 quarters.
NewSquare Capital's Agios Pharmaceuticals position peaked at $182K in Q2 2018.
201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2019.

Based on NewSquare Capital's 13F filing for Q1 2019, filed 25 Apr 2019.